Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$2.58 - $4.99 $41,127 - $79,545
-15,941 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$8.68 - $27.49 $10,876 - $34,444
1,253 Added 8.53%
15,941 $138,000
Q1 2021

May 10, 2021

SELL
$12.0 - $27.64 $2,640 - $6,080
-220 Reduced 1.48%
14,688 $223,000
Q2 2020

Aug 07, 2020

BUY
$9.75 - $17.6 $145,353 - $262,380
14,908 New
14,908 $222,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.